In vitro and in vivo influenza virus-inhibitory effects of viramidine
about
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidasesCurrent and future antiviral therapy of severe seasonal and avian influenzaReplication-Competent Influenza A Viruses Expressing Reporter GenesEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverComparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster modelIn Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus InfectionsThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignNew small-molecule drug design strategies for fighting resistant influenza AReplication-competent fluorescent-expressing influenza B virusGene expression signature-based screening identifies new broadly effective influenza a antiviralsTwo years after pandemic influenza A/2009/H1N1: what have we learned?In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.Combination chemotherapy for influenza.Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.Newer influenza antivirals, biotherapeutics and combinations.Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza.A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusHow to approach and treat viral infections in ICU patientsA curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.Clinical review: update of avian influenza A infections in humans.Epimedium koreanum Nakai Water Extract Exhibits Antiviral Activity against Porcine Epidermic Diarrhea Virus In Vitro and In VivoOseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in miceInosine monophosphate dehydrogenase as a probe in antiviral drug discovery.Exploration of binary virus-host interactions using an infectious protein complementation assayCharacteristics of human infection with avian influenza viruses and development of new antiviral agents.Novel therapies for an old virus: treatment of RSV infections in the 21st Century.Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.Influenza pharmacotherapy: present situation, strategies and hopes.Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses.
P2860
Q21142689-D7E84CD2-815E-4970-BB04-54C957061A0FQ24656164-426A929D-3C91-4D96-AC35-2DAF29B9771EQ26746999-FBC4274E-E244-40B9-B117-262F368E5513Q27457152-E5A1A880-2A87-4C08-8B5F-93F930C79A61Q27478175-94E406FE-2AF0-416C-A9B1-0A16DB90EC86Q27481401-DBCF2063-6128-4A70-AD8C-435DE879005FQ28071809-E8C91FDA-EFA0-4163-8E3C-0CBB341E68BBQ28080554-DFD01682-7566-4D56-ACD1-7F91B740A608Q28387786-3C06A9A9-9B6A-4AFB-B6E9-203846E62A31Q28475681-BBE1BD24-F622-4FBE-9511-CFB0EF26A5E0Q30224656-E8C6EEF8-5926-4F5C-83AF-1B928B3994D2Q30407184-A381BD28-E439-4919-B500-22C642498650Q30408112-7D205388-EA90-40CD-87E9-06B9983B4A85Q30437696-B985CF50-54FD-408C-BB6A-D58E7759F71BQ30456363-F7EC1DCC-B3BA-4249-A984-05B613C322EEQ33875118-26C0E470-E9A6-4654-9926-BB6E36416A5EQ34542805-376326D2-66F2-4811-AAAA-1AA1AE11E875Q34894660-B3B27D76-B662-4D8A-BDD1-4FFA93E032EFQ35332572-1BE367A1-8709-44B6-B8DC-E4A1AE4EEE00Q35647695-56C1E579-B5D8-46AA-AF79-75D17298D305Q36301052-1C7FB680-009B-4E82-9DD6-F3AEFA310126Q36392514-D5E45888-15FE-43D9-9851-9B02AF3B740BQ36464386-C0AA5378-FB39-49D4-B981-91D88FAF5E4EQ36949482-491EB5CB-2B68-4584-8237-54F7DBF4AFB4Q37018993-08AB91C4-E116-4249-8F99-CE99C23F0DE5Q37214687-6EF93110-846E-4A6A-A941-A969EDB6C2BAQ37217863-588C07E3-DCA9-42B8-922C-4FCC6CDA6D8AQ37626071-8300CE6A-3889-45C9-99EE-D3EC910DD3FEQ37828538-BD8B3AD6-6BA2-4E5B-90DD-F17F28EC4908Q37857854-F9F51157-2FC3-405E-A002-9A78E2CA6090Q41821865-7BE5DBB1-4722-4166-AB1D-702E6F93CA2DQ42981047-4F8C1891-9C43-4B39-84BA-8025DC795584
P2860
In vitro and in vivo influenza virus-inhibitory effects of viramidine
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@ast
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@en
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@nl
type
label
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@ast
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@en
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@nl
prefLabel
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@ast
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@en
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@nl
P2093
P3181
P1433
P1476
In vitro and in vivo influenza virus-inhibitory effects of viramidine
@en
P2093
D L Barnard
K W Bailey
Robert W Sidwell
P3181
P356
10.1016/J.ANTIVIRAL.2005.06.003
P407
P577
2005-10-01T00:00:00Z